Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 35,729 | 8,414 | 5,806 | 6,296 | 7,586 |
| Operating Income | -35,729 | -8,414 | -5,806 | -6,296 | -7,586 |
| Other Income | -329 | -280 | -321 | -321 | -301 |
| Pre-tax Income | -36,058 | -8,694 | -6,127 | -6,617 | -7,887 |
| Net Income Continuous | -36,058 | -8,694 | -6,127 | -6,617 | -7,887 |
| Net Income | $-36,058 | $-8,694 | $-6,127 | $-6,617 | $-7,887 |
| EPS Basic Total Ops | -21.60 | -8.80 | -6.00 | -6.40 | -8.00 |
| EPS Basic Continuous Ops | -21.73 | -8.66 | -6.09 | -6.59 | -7.86 |
| EPS Diluted Total Ops | -21.60 | -8.80 | -6.00 | -6.40 | -8.00 |
| EPS Diluted Continuous Ops | -21.73 | -8.66 | -6.09 | -6.59 | -7.86 |
| EBITDA(a) | $-35,300 | $-8,156 | $-5,535 | $-6,010 | $-7,265 |